top of page

Search

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT...

Recommendations on the rollout of COVID-19 vaccines among older adults with cancer

The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer The COVID-19 pandemic...

The EORTC QLU-C10D was more efficient in detecting clinical known group differences

The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L...

A predictive algorithm using clinical and laboratory parameters may assist in diagnosing MDS

The cancer patient’s perspective of COVID‐19‐induced distress

Impact of age on cumulative risk of transformation in patients with chronic myelomonocytic leukaemia

MRI-Based Iron Phenotyping and Patient Selection

The EHA Research Roadmap: Anemias

Core set of patient-reported outcomes for myelodysplastic syndromes

The anemia-independent impact of myelodysplastic syndromes on health-related quality of life

Is Myelodysplasia a Consequence of Normal Aging?

Serologic Responses to COVID-19 Vaccines in Hematological Patients

Feasibility of self-reported electronic patient reported outcome measures in patients with MDS

Patient Reported Outcomes bei PatientInnen mit Myelodysplastischen Syndromen

News

bottom of page